As of May 28, 2026, 48 million shares of our common stock were available for future awards under our equity compensation plans, including 7 million shares approved for issuance under our employee stock purchase plan (“ESPP”).


Nine Months Ended	May 28, 2026		May 29, 2025

Restricted stock award shares granted	7		11
Weighted-average grant-date fair value per share	$	227.18	$	100.25

Employees purchased 2 million shares in each six-month ESPP offering period that ended in the second quarter of 2026 and 2025 at a share price of $92.77 and $78.63, respectively.

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $132 million and $96 million was capitalized and remained in inventory as of May 28, 2026 and August 28, 2025, respectively.


	Quarter Ended				Nine Months Ended
	May 28, 2026		May 29, 2025		May 28, 2026		May 29, 2025

Stock-based compensation expense by caption
Cost of goods sold	$	143	$	115	$	371	$	294
Research and development	129		89		355		254
Selling, general, and administrative	69		59		192		165
	$	341	$	263	$	918	$	713

Stock-based compensation expense by type of award
Restricted stock awards	$	309	$	239	$	829	$	643
ESPP	32		24		89		70
	$	341	$	263	$	918	$	713

As of May 28, 2026, $2.13 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the third quarter of 2030, resulting in a weighted-average period of 1.2 years.